What Is-Charity Organization-Washington-Researching Type 1 Diabetes
All Video Credits you can find here http://broadcaster.beazil.net/public/credits/youtube/videos/42063 Type 1 diabetes (T1D) is an autoimmune disease in which a person’s pancreas stops producing insulin, a hormone people need to get energy from food. T1D strikes both children and adults at any age and suddenly. Its onset has nothing to do with diet or lifestyle. Though T1D’s causes are not yet entirely understood, scientists believe that both genetic factors and environmental triggers play a role. There is currently nothing you can do to prevent it, and there is no cure. Type 1 diabetes strikes both children and adults at any age. It comes on suddenly, causes dependence on injected or pumped insulin for life, and carries the constant threat of devastating complications. Diabetes can affect how you feel each day. If your blood glucose level is too high or too low (hypoglycemia), you may not feel well. Keeping your blood glucose in a target range will help you feel your best. People with type 1 diabetes must take insulin several times a day to keep their blood glucose under control. Welcome to discover inspiring museums, powerful monuments and memorials in Washington, D.C. A diverse, cosmopolitan world capital, D.C. invites visitors to explore its charming neighborhoods, sample its hip shops and restaurants and experience its vibrant nightlife. Fascinating, free attractions and festive events make D.C a favorite destination for travelers from around the world. It is a home for well-known monuments as:Lincoln Memorial, Vietnam Veterans and Korean War Veterans Memorials, National World War II Memorial, Air Force Memorial, American Art Museum, Iwo Jima Memorial, Jefferson Memorial, National Law Enforcement Officers Memorial, Columbus Memorial Fountain, Dupont Circle, Washington Monument, U.S. Navy Memorial ,Martin Luther King, Jr. Memorial, Franklin Delano Roosevelt Memorial, Albert Einstein Memorial, George Mason Memorial, Peace Monument. JDRF is focused on bringing life-changing therapies from the lab to the community by impacting every stage of the drug delivery pipeline. Working the pipeline to expedite and sustain meaningful scientific progress, made possible by our donors, is the key to delivering progressively advanced therapies. This means:
– Driving research across the entire scientific and development spectrum, from discovery in the laboratory to delivery in patients
– Collaborating with public, private, academic and corporate partners to expedite delivery of real-world solutions
– Advocating for progress that will improve lives today and lead to a cure tomorrow JDRF is uniquely positioned to create a future without T1D. The Health Care and Social Assistance industry includes establishments and services such as:
hospitals, nursing and residential care facilities and out-patient care centres; offices of health practitioners (i.e. dentists, doctors, optometrists and chiropractors); medical and diagnostic laboratories; home health care services; ambulance services; social assistance services (i.e. for children, youth, the elderly, families); community food, housing, emergency and relief services; vocational rehabilitation services; and daycare services JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
To sum up, the major issues that were mentioned are:
Insulin Pump Therapy,Research,diabetes diagnosis,Carb Counting,lancet,plasma glucose criteria,diabetic mastopathy,Cystic fibrosis–related diabetes,Glucose Modulating Agents,Grant Management Portal,70/30 insulin,Humulin R,thiazolidinedione,insulin reaction,hypoglycemic episodes,Lee Ducat,FPG value,glycemic control,ACCORD Study,Special Diabetes Program,The Walk to Cure Diabetes,renal threshold of glucose,Managing Type 1,glucose,GLP-1 agonists,Capital City,funding research,support,Celiac Disease and Diabetes,OneWalk,Diabetes,preventive therapies,diabetes mellitus,DKA,Maturity-onset diabetes of the young,DSME,SDP,interstitial glucose,T1D complications,Global Diabetes Research,patient self-monitoring of blood glucose,Artificial Pancreas,blood glucose level,diabetes educator,TypeOnesie,ACCORD Trial,JDRF 2016,juvenile-onset diabetes,Rapid Insulin,PIs,nonprofit funder,heart attack,Medtronic Minimed Insulin Pump Users,Robert Wood Johnson.